Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy

Abstract Photodynamic therapy (PDT) has emerged as an attractive therapeutic approach which can elicit immunogenic cell death (ICD). However, current ICD inducers are still very limited as the representative ICD induces of photosensitizers can only evoke insufficient ICD to achieve unsatisfactory ca...

Full description

Bibliographic Details

Published in:	Journal of Nanobiotechnology
Main Authors:	Haiqin Song, Zhenghao Cai, Juyi Li, Haihua Xiao, Ruogu Qi, Minhua Zheng
Format:	Article
Language:	English
Published:	BMC 2022-07-01
Subjects:	Porphyrin Cisplatin Immunogenic cell death Cancer immunotherapy Photodynamic therapy Nanoparticles
Online Access:	https://doi.org/10.1186/s12951-022-01531-5